Journal of Neurology

, 256:2072 | Cite as

Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation

  • Joana Guimarães
  • Eduarda Matos
  • Maria José Rosas
  • Augusta Vieira-Coelho
  • Nuno Borges
  • Flora Correia
  • Rui Vaz
  • Carolina Garrett
Original Communication

Abstract

Chronic bilateral subthalamic stimulation (DBS-STN) provides considerable clinical benefits in Parkinson disease patients, with improvement in primary symptoms and resolution of side effects of chronic pharmacological treatment. Apart from its therapeutic effects on PD symptoms, DBS-STN also appears to induce weight gain, which may itself induce critical metabolic disorders and limit the benefits of surgery. No data are available in literature showing the efficacy of a nutritional intervention to prevent rapid and/or excessive weight gain after DBS-STN. Fifty-seven PD patients were included in this study and were divided into two groups: Group 1 comprised 16 patients with a nutritional intervention immediately after surgery (1 week after); Group 2 comprised 41 patients with a nutritional intervention in a later period after surgery (mean time of 2.5 ± 1.6 years). Weight, body mass index (BMI), percentage of fat mass, levodopa daily dose (LDD) and part III of the Unified Parkinson’s disease rating scale (UPDRS) were studied before and after an individualized and structured nutritional intervention. Three months after nutritional intervention, Group 1 had a mean BMI (24.1 ± 2.99), that was not significantly different (p = 0.114) from BMI before intervention, with stability of the weight and in percentage of fat mass. In Group 2 all the patients gained weight, reaching to 13.17 ± 10%; a total of 63% of patients became overweight (BMI 25 kg/m2). Three months after nutritional intervention, Group 2 had a mean BMI (24.80 ± 2.45) that was significantly (p = 0.03) different from BMI before intervention (26.75 ± 2.99), although percentage of fat mass was higher in women. With this study, we have conclude that nutritional intervention adequate to patient-age, disease characteristics, medical therapy with l-dopa and physical activity, is effective incontrolling weight after DBS-STN surgery.

Keywords

Nutritional intervention Bilateral subthalamic Nucleus stimulation Energy metabolism 

Notes

Acknowledgments

The authors would like to thank to Clinical Investigation Center of Hospital de São João.

References

  1. 1.
    Volkmann J, Albert N, Voges J, Weiss PH, Freund HJ, Sturm V (2001) Safety and efficacy of pallidal and subthalamic nucleus stimulation in advanced PD. Neurology 56:548–551PubMedGoogle Scholar
  2. 2.
    Anheim M, Batir A, Fraix V, Silem M, Chabardès S, Seigneuret E (2008) Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation. Arch Neurol 65(5):612–616CrossRefPubMedGoogle Scholar
  3. 3.
    Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S et al (2005) Brain bilateral deep brain stimulation in Parkinson’s disease a multicentre study with 4 years follow-up. Brain 128(Pt 10):2240–2249CrossRefPubMedGoogle Scholar
  4. 4.
    Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM et al (2005) Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5-year follow up. J Neurol Neurosurg Psychiatry 76(12):1640–1644CrossRefPubMedGoogle Scholar
  5. 5.
    Gironell A, Pascual-Sedano B, Otermin P, Kulisevsky J (2002) Weight gain after functional surgery for Parkinson’s disease. Neurologia 17:310–316PubMedGoogle Scholar
  6. 6.
    Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G (2003) Body weight gain rate in patients with Parkinson’s disease and deep brain stimulation. Mov Disord 18:1337–1340CrossRefPubMedGoogle Scholar
  7. 7.
    Macia F, Perlemoine C, Coman I, Guehl D, Burbaud P, Cuny E et al (2004) Parkinson’s disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 19(2):206–212CrossRefPubMedGoogle Scholar
  8. 8.
    Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Billington CJ, Laseski MA et al (2005) Weight and body mass index in Parkinson’s disease patients after deep brain stimulation surgery. Parkinsonism Relat Disord 11(4):247–252CrossRefPubMedGoogle Scholar
  9. 9.
    Perlemoine C, Macia F, Tison F, Coman I, Guehl D, Burbaud P et al (2005) Effects of subthalamic nucleus deep brain stimulation and l-dopa on energy production rate and substrate oxidation in Parkinson’s disease. Br J Nutr 93:191–198CrossRefPubMedGoogle Scholar
  10. 10.
    Montaurier C, Morio B, Bannier S, Derost P, Arnaud P, Brandolini-Bunlon M et al (2007) Mechanisms of body weight gain in patients with Parkinson’s disease after subthalamic stimulation. Brain 130(7):1808–1818CrossRefPubMedGoogle Scholar
  11. 11.
    Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 16:7–1872Google Scholar
  12. 12.
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289(1):76–79Google Scholar
  13. 13.
    Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A (2002) Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg 97:591–597CrossRefPubMedGoogle Scholar
  14. 14.
    Consensus Conference Proceedings (2000) Parkinson’s disease: diagnostic and therapeutic criteria. Rev Neurol (Paris) 156:7–294Google Scholar
  15. 15.
    Elia M, Ward LC (1999) New techniques in nutritional assessment: body composition methods. Proc Nutr Soc 58(1):33–38CrossRefPubMedGoogle Scholar
  16. 16.
    Siri W (1961) Body composition from fluid spaces and density: analyses of methods. National Academic of Sciences, WashingtonGoogle Scholar
  17. 17.
    Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32(1):77–97CrossRefPubMedGoogle Scholar
  18. 18.
    Metropolitan height and weight tables (1983) Stat Bull Metrop Life Found 64(1):3–9Google Scholar
  19. 19.
    FAO/OMS. Rapport d’un comité spécial mixte FAO/OMS d’experts. Besoins énergétiques et besoins en protéines. Série de Rapports techniques; 1973:522Google Scholar
  20. 20.
    Bagnasco M, Dube MG, Kalra PS (2002) Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143(11):4409–4421CrossRefPubMedGoogle Scholar
  21. 21.
    Langston JW, Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3:129–133CrossRefPubMedGoogle Scholar
  22. 22.
    Lipp A, Tank J, Trottenberg T, Kupsch A, Arnold G, Jordan J (2005) Sympathetic activation due to deep brain stimulation in the region of the STN. Neurology 65:774–775CrossRefPubMedGoogle Scholar
  23. 23.
    Liu LL, Li BM, Yang J, Wang YW (2008) Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD? Med Hypotheses 70(6):1118–1120CrossRefPubMedGoogle Scholar
  24. 24.
    Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354–357CrossRefPubMedGoogle Scholar
  25. 25.
    Simon N, Gantcheva R, Bruguerolle B, Viallet F (2004) The effects of a normal protein diet on levodopa kinetics in advanced Parkinson’s disease. Parkinsonism Relat Disord 10:137–142CrossRefPubMedGoogle Scholar
  26. 26.
    Bracco MalesaniR, Saladani M (1991) Protein redistribution diet and antiparkinsonian response to levodopa. Eur Neurol 31(2):68–71CrossRefPubMedGoogle Scholar
  27. 27.
    Berry EM, Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ (1991) A balanced carbohydrate: protein diet in the management of Parkinson’s disease. Neurology 41:1295–1297PubMedGoogle Scholar
  28. 28.
    Stamler J, Neaton JD (2008) The multiple risk factor intervention trial (MRFIT)—importance then and now. JAMA 300(11):1343–1345CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Joana Guimarães
    • 1
  • Eduarda Matos
    • 2
  • Maria José Rosas
    • 3
  • Augusta Vieira-Coelho
    • 4
  • Nuno Borges
    • 4
  • Flora Correia
    • 5
  • Rui Vaz
    • 6
  • Carolina Garrett
    • 1
  1. 1.Department of Neurology, Faculty of Medicine, University of Porto, Hospital de São JoãoSão João HospitalPortoPortugal
  2. 2.Faculty of Nutrition SciencesSão João HospitalPortoPortugal
  3. 3.Department of NeurologySão João HospitalPortoPortugal
  4. 4.Institute of Pharmacology and Therapeutics, Faculty of MedicineSão João HospitalPortoPortugal
  5. 5.Faculty of Nutrition Sciences, University of PortoSão João HospitalPortoPortugal
  6. 6.Neurosurgery Department, Faculty of Medicine, University of Porto, Hospital de São JoãoSão João HospitalPortoPortugal

Personalised recommendations